Why the study?
The predictive value of 7 routinely available inflammation biomarkers for stroke and all-cause mortality in non-valvular AF patients was evaluated.
Do 7 routinely available inflammation biomarkers predict stroke and all-cause mortality in patients with non-valvular atrial fibrillation?
Do 7 routinely available inflammation biomarkers predict stroke and all-cause mortality in patients with non-valvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Routinely available inflammation biomarkers may improve the prediction of all-cause mortality when added to standard risk scores in patients with non-valvular atrial fibrillation.
BACKGROUND: This study aimed to assess the predictive value of 7 routinely available inflammation biomarkers for stroke and all-cause mortality in 229 non-valvular AF patients. METHODS AND CONCLUSIONS: -VASc score increased its ability to predict all-cause mortality, suggesting this cost-effective biomarker strategy may help to improve decision support in AF.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: